MedTrace Logo

LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer

NCT01561443 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2016-01-11

No results posted yet for this study

Summary

This is the first study focused on features/stereotypes of the first and second-line treatment patterns in Russia, comparison of different treatments, and determination of effective hormone treatment patterns in real-life practice with evaluation of pharmacoeconomic aspects. Study LINE is designed for collection of data on clinical effectiveness of second-line hormone treatment and quality of life in patients with breast cancer(BC).

Conditions

  • Local Advanced or Metastatic Postmenopausal Breast Cancer

Sponsors & Collaborators

Principal Investigators

  • Alexey Stepanov, Prof. · AstraZeneca

  • Maria Konstantinova, Prof · Russian Oncology Scientific Center

  • Sergey Gutorov, Prof. · Russian Oncology Scientific Center

  • Marina Stenina, PhD · Surgery Institute named after A.V. Vishnevskiy

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01561443 on ClinicalTrials.gov